[DOI] [PMC free article] [PubMed] [Google Scholar] Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI
GLP-1 and energy balance: An integrated model of short-term and long-term control
4.3 Comparative safety profiles of biomaterial and systemic therapeutic approaches Biomaterial delivery platforms can markedly reduce the off-target toxicities of systemic immunotherapies by concentrating antigen or immunomodulatory cargo in tolerogenic tissues or the diseased microenvironment, enabling lower total doses, controlled release, and biomimetic presentation that better recapitulates apoptotic-cell-driven tolerance (206, 207)
Some can, especially when circulation and sensation are normal
[DOI] [PMC free article] [PubMed] [Google Scholar] 179.Faraji N, Arab SS, Doustmohammadi A, Daly NL, Khosroushahi AY
A providers comfort level with these medications can significantly impact your treatment experience